SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 1094.95 millions against Rs. 1047.78 millions during year ago period.Net Profit of the company move down -31.97% to Rs. 30.05  millions from Rs. 44.17 millions  in the same quarter last year.Operating profit for the quarter ended June 2022 decreased to 103.84 millions as compared to 108.72 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1094.95 1047.78 4.50 1094.95 1047.78 4.50 4510.68 3846.98 17.25
Other Income 0.07 5.22 -98.66 0.07 5.22 -98.66 0.89 0.00 0.00
PBIDT 103.84 108.72 -4.49 103.84 108.72 -4.49 491.45 580.20 -15.30
Interest 35.45 29.62 19.68 35.45 29.62 19.68 111.62 93.26 19.69
PBDT 68.39 79.10 -13.54 68.39 79.10 -13.54 379.83 486.94 -22.00
Depreciation 26.00 23.90 8.79 26.00 23.90 8.79 102.49 91.75 11.71
PBT 42.39 55.20 -23.21 42.39 55.20 -23.21 277.34 395.19 -29.82
TAX 12.34 11.03 11.88 12.34 11.03 11.88 80.76 115.48 -30.07
Deferred Tax -0.96 -4.22 -77.25 -0.96 -4.22 -77.25 -7.32 22.80 -132.11
PAT 30.05 44.17 -31.97 30.05 44.17 -31.97 196.58 279.71 -29.72
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 9.48 10.38 -8.60 9.48 10.38 -8.60 10.90 15.08 -27.76

Mangalam Drugs&Org. Share Price

29.75 0.02 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×